Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Bibliographic Details
Main Authors: Douillard, Jean-Yves, Ostoros, Gyula, Cobo, Manuel, Ciuleanu, Tudor, Cole, Rebecca, McWalter, Gael, Walker, Jill, Dearden, Simon, Webster, Alan, Milenkova, Tsveta, McCormack, Rose
Format: Online
Language:English
Published: Lippincott Williams & Wilkins 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224589/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224589/

Similar Items